Biofilm formation and antibiotic resistance of clinical isolates from diabetic foot ulcers

  • Received 05.05.2025

  • Revised 24.07.2025

  • Accepted 02.09.2025



  • 539 Views

  • Retrieved from Vol. 7, No. 3, 2025

  • Pages 46-53

Diabetic foot ulcers are among the most debilitating complications of type 2 diabetes mellitus, often leading to persistent infections and lower limb amputations. Microbial colonisation and biofilm formation contribute significantly to the chronicity and antibiotic resistance observed in these wounds. This study aimed to investigate the spectrum of microorganisms isolated from diabetic foot ulcers, assess their antibiotic susceptibility, and evaluate the biofilm-forming capacity of Staphylococcus aureus strains. Microbiological examination of wound discharge was performed for 68 patients with clinically diagnosed diabetic foot syndrome. A total of 78 microbial isolates were identified using morphological and biochemical methods. Most wound infections were monocultures (85%), with mixed infections identified in 10 cases. Antibiotic susceptibility was tested using the Kirby-Bauer disk diffusion method. Biofilm formation in Staphylococcus aureus isolates was assessed under static conditions using gentian violet staining and semi-quantitative scoring. Gram-positive bacteria predominated (73%), with Staphylococcus aureus and Staphylococcus haemolyticus being the most frequently isolated. Among Gram-negative organisms (27%), Klebsiella spp. and Pseudomonas aeruginosa were common. Antibiotic susceptibility testing revealed moderate methicillin sensitivity in Staphylococcus aureus (40%) and Staphylococcus haemolyticus (44%), while vancomycin and tigecycline showed the highest activity. Macrolides were largely ineffective, and Corynebacterium spp. demonstrated extensive resistance. Gram-negative isolates displayed higher resistance overall, with Klebsiella spp. resistant to most tested antibacterials. Biofilm formation analysis of 25 Staphylococcus aureus isolates revealed biofilm formation in 48%, including weak (58%), moderate (17%), and strong (25%) producers. Routine screening for biofilm-producing pathogens may improve clinical management and outcomes in diabetic foot infections

antibiotic susceptibility; chronic wounds; multidrug resistance; S. aureus; wound microbiota

https://doi.org/10.63341/bmbr/3.2025.46

[1] Kumar A, Gangwar R, Ahmad Zargar A, Kumar R, Sharma A. Prevalence of diabetes in India: A review of IDF diabetes atlas 10th edition. Curr Diabetes Rev. 2024;20(1):e130423215752. DOI: 10.2174/1573399819666230413094200

[2] Nabrdalik K, Kwiendacz H, Moos J, Moos Ł, Kulpa J, Brzoza Z, et al. Diabetic peripheral neuropathy is associated with diabetic kidney disease and cardiovascular disease: The Silesia Diabetes-Heart Project. Curr Probl Cardiol. 2023;48(8):101726. DOI: 10.1016/j.cpcardiol.2023.101726

[3] Stancu B, Ilyés T, Farcas M, Coman HF, Chiș BA, Andercou OA. Diabetic foot complications: A retrospective cohort study. Int J Environ Res Public Health. 2023;20(1):187. DOI: 10.3390/ijerph20010187

[4] Moore Z, Avsar P, Wilson P, Mairghani M, O’Connor T, Nugent L, et al. Diabetic foot ulcers: Treatment overview and cost considerations. J Wound Care. 2021;30(10):786–91. DOI: 10.12968/jowc.2021.30.10.786

[5] Parveen K, Hussain MA, Anwar S, Elagib HM, Kausar MA. Comprehensive review on diabetic foot ulcers and neuropathy: Treatment, prevention and management. World J Diabetes. 2025;16(3):100329. DOI: 10.4239/wjd.v16.i3.100329

[6] Volch I, Mykhailyshyn H, Pokotylo O, Hetman U, Bukata V. Microbiological analysis of wound content in patients with type 2 diabetes mellitus with diabetic foot syndrome. Int J Med Med Res. 2024;10(1):6–14. DOI: 10.61751/ijmmr/1.2024.06

[7] Afonso AC, Oliveira D, Saavedra MJ, Borges A, Simões M. Biofilms in diabetic foot ulcers: Impact, risk factors and control strategies. Int J Mol Sci. 2021;22(15):8278. DOI: 10.3390/ijms22158278

[8] Ivanova YV, Gramatiuk SM, Kryvoruchko IA, Goloborodko MM, Miasoiedov KV, Knyhin MV, et al. Biofilm-forming mechanisms in diabetic foot syndrome pathogens: Adhesive properties and interaction in associations. Clin Prev Med. 2025;5:37–44. DOI: 10.31612/2616-4868.5.2025.05

[9] Piksa M, Fortuna W, Lian C, Gacka M, Samuel IDW, Matczyszyn K, et al. Treatment of antibiotic-resistant bacteria colonizing diabetic foot ulcers by OLED induced antimicrobial photodynamic therapy. Sci Rep. 2023;13:14087. DOI: 10.1038/s41598-023-39363-4

[10] Naaz T, Lahiri D, Pandit S, Nag M, Gupta PK, Al-Dayan N, et al. Antimicrobial peptides against microbial biofilms: Efficacy, challenges, and future prospect. Int J Pept Res Ther. 2023;29(3):48. DOI: 10.1007/s10989-023-10519-0

[11] Kravets NY, Klumnyk SI, Romanyuk LB, Borak VP. Biofilm-forming properties of pathogenic microorganisms in children with recurrent tonsillitis. World Med Biol. 2022;80(2):210–3. DOI: 10.26724/2079-8334-2022-2-80-210-213

[12] Pouget C, Dunyach-Remy C, Pantel A, Schuldiner S, Sotto A, Lavigne JP. Biofilms in diabetic foot ulcers: Significance and clinical relevance. Microorganisms. 2020;8(10):1580. DOI: 10.3390/microorganisms8101580

[13] Weinstein MP, Lewis JS. Performance standards for antimicrobial susceptibility testing. 30th ed. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI); 2020. 332 P.

[14] Wilson C, Lukowicz R, Merchant S, Valquier-Flynn H, Caballero J, Sandoval J, et al. Quantitative and qualitative assessment methods for biofilm growth: A mini-review. Res Rev J Eng Technol. 2017;6(4):1–42.  

[15] Stepanović S, Vuković D, Dakić I, Savić B, Švabić-Vlahović M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175–9. DOI: 10.1016/s0167-7012(00)00122-6

[16] UNESCO. Universal Declaration on Bioethics and Human Rights [Internet]. 2005 October 19 [cited 2025 April 25]. Available from: https://www.unesco.org/en/legal-affairs/universal-declaration-bioethics-and-human-rights?hub=66535

[17] The World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [Internet]. [cited 2025 April 25]. Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-princip.2024

[18] Banu A, Noorul Hassan MM, Rajkumar J, Srinivasa S. Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: A prospective study. Australas Med J. 2015;8(9):280–5. DOI: 10.4066/AMJ.2015.2422

[19] Du F, Ma J, Gong H, Bista R, Zha P, Ren Y, et al. Microbial infection and antibiotic susceptibility of diabetic foot ulcer in China: Literature review. Front Endocrinol (Lausanne). 2022;13:881659. DOI: 10.3389/fendo.2022.881659

[20] Soldevila-Boixader L, Carrera-Salinas A, Mur I, Morata L, Rivera A, Bosch J, et al. Exploring the microbiome of diabetic foot ulcers: A focus on cases with a clinical worse outcome. Antibiotics. 2025;14(7):724. DOI: 10.3390/antibiotics14070724

[21] Garousi M, Monazamitabar S, Mirazi H, Farrokhi Z, Khaledi A, Shakerimoghaddam A. Epidemiology of Pseudomonas aeruginosa in diabetic foot infections: A global systematic review and meta-analysis. Germs. 2023;13(4):362–72. DOI: 10.18683/germs.2023.1406

[22] Dörr S, Holland-Letz AK, Weisser G, Chatzitomaris A, Lobmann R. Bacterial diversity, antibiotic resistance, and the risk of lower limb amputation in younger and older individuals with diabetic foot infection. Int J Low Extrem Wounds. 2021;22(1):63–71. DOI: 10.1177/1534734621992290

[23] Anafo RB, Atiase Y, Dayie NTKD, Kotey FCN, Tetteh-Quarcoo PB, Duodu S, et al. Methicillin-resistant Staphylococcus aureus (MRSA) infection of diabetic foot ulcers at a tertiary care hospital in Accra, Ghana. Pathogens. 2021;10(8):937. DOI: 10.3390/pathogens10080937

[24] Matta-Gutiérrez G, García-Morales E, García-Álvarez Y, Álvaro-Afonso FJ, Molines-Barroso RJ, Lázaro-Martínez JL. The influence of multidrug-resistant bacteria on clinical outcomes of diabetic foot ulcers: A systematic review. J Clin Med. 2021;10(9):1948. DOI: 10.3390/jcm10091948

 [25] Yang S, Hu L, Zhao Y, Meng G, Xu S, Han R. Prevalence of multidrug‐resistant bacterial infections in diabetic foot ulcers: A meta‐analysis. Int Wound J. 2024;21(4):e14864. DOI: 10.1111/iwj.14864

 [26] Mamdoh H, Hassanein KM, Eltoony LF, Khalifa WA, Hamed E, Alshammari TO, et al. Clinical and bacteriological analyses of biofilm-forming staphylococci isolated from diabetic foot ulcers. Infect Drug Resist. 2023;16:1737–50. DOI: 10.2147/IDR.S393724